✦ LIBER ✦

492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin

✍ Scribed by P. Marcellin; Y. Horsmans; F. Nevens; J.D. Grange; J.P. Bronowicki; D. Vetter; R. Kauffman; S. Knox; L. McNair; S. Moseley; J. Alam

Book ID: 117373320
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 63 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(04)90492-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with interferon alfa

Combination therapy with interferon alfa-2B, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin

✍ Hemant Pande; Paul J Thuluvath; Salim A Jaffer; Joyce Maygers 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Cutaneous sarcoidosis limited to scars f

Cutaneous sarcoidosis limited to scars following pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C

✍ S Perez-Gala; Y Delgado-Jimenez; R Goiriz; J Fernandez-Herrera; J Fraga; A Garci 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Efficacy and Tolerability of Combination

Efficacy and Tolerability of Combination Therapy with Interferon-Alfa Plus Ribavirin in Patients with Chronic Hepatitis C Virus Infection: A Single-Center Study in Relapsers and Nonresponders to Previous Treatment with High-Dose Interferon-Alfa Monotherapy

✍ Federica Benini; Luciana Distefano; Ornella Baisini; Marie Graciella Pigozzi; Al 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Virological response and safety outcomes

Virological response and safety outcomes in therapy–naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study

✍ Robert G. Gish; Sanjeev Arora; K. Rajender Reddy; David R. Nelson; Christopher O 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of

Early decrease of the viremia with ribav

Early decrease of the viremia with ribavirin and interferon combination therapy in patients with chronic hepatitis C non responders to the interferon

✍ P. Vega; M. Hermida; A. Castro; S.López Calvo; J. Baliñas; R. Torrón; JD. Pedrei 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 134 KB